Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
Schwickert M, Fischer TR, Zimmermann RA, Hoba SN, Meidner JL, Weber M, Weber M, Stark MM, Koch J, Jung N, Kersten C, Windbergs M, Lyko F, Helm M, Schirmeister T
J Med Chem. 2022 Jul 18. doi: 10.1021/acs.jmedchem.2c00388.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article